[NavBar.htm]

Senior Journal: Today's News and Information for Senior Citizens & Baby Boomers

More Senior Citizen News and Information Than Any Other Source - SeniorJournal.com

Go to more on Health & Medicine or More Senior News from SeniorJournal.com on the Front Page

   
Follow on  and 

E-mail this page to a friend!

Health & Medicine for Senior Citizens

Lipitor, Plavix Among Big-Name Drugs Falling Off The 'Patent Cliff'

Some of the most popular and expensive brand-name drugs are about to go generic

By Fred Mogul, WNYC

File photo by Jessica Marcy/KHN

Oct. 24, 2011 - Take Lipitor, for example. In November, the heart drug comes off-patent and by next June, there are likely to be multiple generic versions.

With almost $11 billion in sales last year, it's the largest blockbuster to fall off what analysts call the "patent cliff." And it's just one of dozens of popular high-end pharmaceuticals whose prices are expected to plummet in the coming years, including drugs like Plavix (for heart disease), Seroquel (used to treat depression) and Nexium (for digestive problems.)

This story is part of a reporting partnership among NPR, Kaiser Health News and NPR member stations.

Listen to the
Story on NPR

Patients often pay more for name-brand drugs, even when they're covered by insurance. Sometimes they have no choice because unlike Lipitor many drugs don't yet have generic competition.

Howard Weintraub, a cardiologist at New York University, says many patients on those drugs come in and beg for free samples. Others simply don't fill their prescriptions or they do, but then try to stretch their resources by taking the pricey pills less often than they're supposed to.

"People come in with their blood pressure not as well controlled, or they come in and their cholesterol's all of a sudden mysteriously higher. And you realize, OK, the medicine hasn't stopped working, but you also realize the medicine doesn't work when it's still in the bottle," he says.

 

Related Archive Stories

 
 

Shortages Lead Doctors To Ration Critical Drugs for Wide Range of Problems

Click for larger view'We know this is a dire public health situation,' Assistant Secretary of Health and Human Services Howard Koh

By Richard Knox, NPR News

Oct. 4, 2011

Beyond Pills: Cardiologists Examine Alternatives to Reduce High Blood Pressure

Growing number require a large number of drugs to control blood pressure and look for something to help

August 30, 2011


 
 

Read the latest news
> Health & Medicine
>
Today's Headlines

 

Generics already represent 70 to 80 percent of drug sales a dominance expected to grow in the future. Michael Kleinrock, of marketing research firm IMS Health, says patent expirations over the last half-decade are one of the main reasons why Medicare spent $50 billion less than federal officials projected five years earlier.

FDA approves Zyprexa: first generic to treat schizophrenia, bipolar disorder

10/24/11 - The U.S. Food and Drug Administration today approved the first generic versions of Zyprexa (olanzapine tablets) and Zyprexa Zydus (olanzapine orally disintegrating tablets) to treat schizophrenia and bipolar disorder.

Schizophrenia is a chronic, severe, and disabling brain disorder. About 1 percent of Americans have this illness. Symptoms people with schizophrenia have include: hearing voices, believing other people are reading their minds or controlling thoughts, and being suspicious or withdrawn.

Bipolar disorder, also known as manic-depressive illness, is a brain disorder that causes unusual shifts in mood, energy, activity levels, and the ability to carry out day-to-day tasks. The symptoms of bipolar disorder include alternating periods of depression and high or irritable mood, increased activity and restlessness, racing thoughts, talking fast, impulsive behavior, and a decreased need for sleep.


Generic drugs approved by FDA have the same high quality, strength, purity, and stability as brand-name drugs. The generic manufacturing, packaging, and testing sites must pass the same quality standards as those of brand name drugs.


 

Kleinrock says the average daily cost of drugs dropped one-third from 2005 to 2010, and should drop another third between now and 2015.

"We're already at reasonably low cost relative to 10 years ago or so," he adds. "That said, there's still actually more to go, which is excellent for consumers."

The drop in drug costs because of generics is one of the few bright spots in all of American health care. But it isn't exactly a big bright spot.

"For sure it will be felt, but because the other things are on such a heavy rise, it will only temper where rates are currently," says Dr. Dennis Liotta, the head of pharmaceutical benefits for Emblem Health, one of New York's largest insurers.

Liotta says the generic drug savings is significant and especially visible to people with limited means and limited health coverage. But drugs are a relatively small factor in insurance premiums.

And while blockbuster drugs like Lipitor are sunsetting, University of Michigan business school professor Erik Gordon says pharmaceutical companies are trying to replace them with new, more targeted drugs like Pfizer's recently approved lung-cancer medication.

"The interesting thing is it will work in only 5 percent of lung cancer patients. The other interesting thing is it's going to cost $115,000 per year, per patient," Gordon says.

Some analysts say the growing field of costly specialty drugs could undermine the growing savings from generics. But Gordon says drug companies will still have their work cut out for them. It's getting tougher not only to come up with new drugs, he says, but also to convince insurers and the government to pay for them unless they make meaningful improvements in health, at a reasonable cost.

Links below may contain updates and reader comments:

>> Original story on NPR Health Blog, SHOTS

>> Also on Kaiser Health News

Some of this information is reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Health Policy Report, search the archives and sign up for email delivery. Henry J. Kaiser Family Foundation. All rights reserved.

 

> Medical Malpractice,

> Nursing Home Abuse,

> Personal Injury

Our Experienced Lawyers Can Help

Beth Janicek, Board Certified Personal Injury Attorney"We win because we care, we prepare and we have no fear," Beth Janicek, board certified personal injury attorney

 

Free Consultation on your case.

Call Now Toll Free

1-877-795-3425

or Send Email

More at our Website

 

 

Search for more about this topic on SeniorJournal.com

Google Web SeniorJournal.com

Keep up with the latest news for senior citizens, baby boomers

 

Click to More Senior News on the Front Page

Copyright: SeniorJournal.com

    

 

Published by New Tech Media - www.NewTechMedia.com

Other New Tech Media sites include CaroleSutherland.com, BethJanicek.com, SASeniors.com, DrugDanger.com, etc.